ESMO 2024 special: Results of interim analysis of SunRISe-4

ESMO 2024 special: Results of interim analysi...

Up next

AI in urology: Ep.3 Mrs. Collen and Dr. Kowalewski discuss AI policy

In Episode 3, “AI policy in urology” of the series “AI in urology: From principles to practice”, Sarah Collen (BE) and Dr. Karl Kowalewski (DE) discuss the critical role of policy and regulation in the development and use of artificial intelligence in urology.The conversation hig ...  Show more

AI in urology: Ep.2 Prof. Somani and Dr. De Backer discuss AI in education

In Episode 2, “AI in urology education” of the series “AI in urology: From principles to practice”, Prof. Bhaskar Somani (UK) and Dr. Pieter De Backer (BE) discuss the growing role of artificial intelligence in urological training and education.The conversation focuses on how AI ...  Show more

Recommended Episodes

Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
BackTable Urology

Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ...  Show more

AI in Quantitative CT Assessments: CONFIRM2 with Dr Alexander Van Rosendael
The Radcliffe Cardiology Podcast

In this episode of the "Innovations in Cardiology" series, host Dr Dipti Itchhaporia (Hoag Heart and Vascular Institute, Newport Beach, CA, US) is joined by Dr Alexander Van Rosendael (Leiden University Medical Center, Leiden, NL) to discuss the findings from the CONFIRM2 trial. ...  Show more

Evolut Low-Risk Trial: 5-year Data Outcomes
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Transcatheter aortic valve replacement (TAVR) has emerged as the preferred treatment for aortic stenosis. However, there is a lack of long-term outcome data for low-risk patients. The 5-year results from the Evolut Low-Risk randomized trial address this gap, offering compelling e ...  Show more

PARP Inhibitors in Advanced Prostate Cancer Care
AUAUniversity

PARP Inhibitors in Advanced Prostate Cancer Care Podcast CME Available: https://auau.auanet.org/node/37321 Host: Jay D. Raman, MD, FACS Guests: Maha Hussain, MD and Ganesh Raj, MD, PhD LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Identi ...  Show more